Boehringer Ingelheim: all 2,305 studies
Page 13 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung FibrosisActive, not recruitingNCT07080125
- A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the BodyCompletedNCT07071974Phase 1
- A Study to Test How BI 1819479 is Taken up and Processed by the BodyTerminatedNCT07065617Phase 1
- SGLT2 Inhibitors and Renal Anemia in Japan: RWDActive, not recruitingNCT07063316
- A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentActive, not recruitingNCT07036523Phase 2
- A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and TogetherCompletedNCT07035457Phase 1
- A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity DisorderCompletedNCT07001475Phase 1
- A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy AdultsCompletedNCT06984926Phase 1
- A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)Active, not recruitingNCT06962852Phase 1/2
- A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With FoodCompletedNCT06962826Phase 1
- A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver ProblemsCompletedNCT06957756Phase 1
- A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by FoodCompletedNCT06955754Phase 1
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseCompletedNCT06926660Phase 2
- A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the BloodCompletedNCT06917872Phase 1
- A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and WomenSuspendedNCT06916702Phase 1
- The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take NintedanibCompletedNCT06912659
- Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular PsoriasisWithdrawnNCT06886009
- A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or PancreasTerminatedNCT06882746Phase 1
- A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 InterferonopathiesActive, not recruitingNCT06878365Phase 1
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab AloneActive, not recruitingNCT06806852Phase 1
- A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic DiseasesActive, not recruitingNCT06806592Phase 3
- A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the BodyCompletedNCT06791187Phase 1
- A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of SchizophreniaCompletedNCT06791122Not applicable
- A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the BodyCompletedNCT06772532Phase 1
- A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyActive, not recruitingNCT06769048Phase 2
- A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With ObesityActive, not recruitingNCT06745284Phase 1
- A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyCompletedNCT06722157Phase 2
- A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASHCompletedNCT06675929Phase 2
- A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the BodyCompletedNCT06655220Phase 1
- A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the BloodCompletedNCT06647810Phase 1
- A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy MenCompletedNCT06631430Phase 1
- A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different FormulationsCompletedNCT06631417Phase 1
- A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking BuprenorphineTerminatedNCT06628622Phase 1
- A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This MedicineActive, not recruitingNCT06619509Phase 2
- A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the BodyTerminatedNCT06572111Phase 1
- A Study to Test Whether BI 456906 (Survodutide) Influences the Amount of Bupropion, Caffeine and Midazolam in the Blood in People With Overweight or ObesityCompletedNCT06564441Phase 1
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)Active, not recruitingNCT06531824Phase 3
- Post Marketing Surveillance of JARDIANCE in Chronic Kidney DiseaseActive, not recruitingNCT06527846
- A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different WaysCompletedNCT06520514Phase 1
- A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)TerminatedNCT06515002Phase 1/2
- A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese MenCompletedNCT06494774Phase 1
- A Study in Chinese People With Overweight or Obesity to Test How Different Doses of Survodutide Are Taken up in the BodyCompletedNCT06492135Phase 1
- Real-life-persistence to Antifibrotic TreatmentsCompletedNCT06485635
- A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the BloodCompletedNCT06419660Phase 1
- Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue SarcomaWithdrawnNCT06370871Phase 3
- A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Healthy Men and People With Overweight or ObesityCompletedNCT06352437Phase 1
- A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain ActivityCompletedNCT06352424Phase 1
- A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney ProblemsCompletedNCT06352411Phase 1
- A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT06335303Phase 2
- A Study in Healthy People to Test How Well Different Doses of BI 3000202 Are Tolerated and How They Affect the Way the Body Handles MidazolamCompletedNCT06327256Phase 1
- A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)CompletedNCT06309992Phase 3
- A Study to Test How Avenciguat (BI 685509) is Taken up in the Body of People With and Without Liver ProblemsTerminatedNCT06272058Phase 1
- A Study in Healthy Men to Test How Different Doses of BI 3031185 Are Tolerated and How Food Influences the Amount of BI 3031185 in the BloodCompletedNCT06255340Phase 1
- A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodCompletedNCT06241560Phase 2
- A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With NerandomilastActive, not recruitingNCT06238622Phase 3
- A Study to Test How Well Multiple Doses of BI 765423 Are Tolerated by Healthy MenCompletedNCT06232252Phase 1
- A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose WeightCompletedNCT06214741Phase 3
- A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or ObesityCompletedNCT06200467Phase 1
- A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the BloodCompletedNCT06193811Phase 1
- A Study to Test Whether Survodutide Helps Japanese People Living With Obesity DiseaseCompletedNCT06176365Phase 3
- Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentActive, not recruitingNCT06151574Phase 3
- A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are ToleratedCompletedNCT06148948Phase 1
- A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are ToleratedCompletedNCT06139341Phase 1
- IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart AttackTerminatedNCT06139328Phase 2
- A Study to Test How Well Different Doses of BI 765845 Are Tolerated by Healthy PeopleCompletedNCT06139315Phase 1
- DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine CancersActive, not recruitingNCT06132113Phase 1
- A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6TerminatedNCT06091930Phase 1
- A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are ToleratedCompletedNCT06081530Phase 1
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)CompletedNCT06077864Phase 3
- DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung CancerActive, not recruitingNCT06077500Phase 1
- A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac SafetyCompletedNCT06070597Phase 1
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose WeightCompletedNCT06066528Phase 3
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightCompletedNCT06066515Phase 3
- Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated LiposarcomaCompletedNCT06058793Phase 3
- A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and OesophagusCompletedNCT06056024Phase 1
- A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy MenCompletedNCT06006598Phase 1
- A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic AtrophyCompletedNCT06006585Phase 1
- DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent ChemotherapyActive, not recruitingNCT05990738Phase 1
- A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are ToleratedCompletedNCT05985200Phase 1
- Describing Patient With DME, Their Patient Journey and Disease ProgressionCompletedNCT05966753
- A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)CompletedNCT05934955Phase 1
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the BloodCompletedNCT05896384Phase 1
- Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in FranceActive, not recruitingNCT05882071
- A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3Active, not recruitingNCT05879978Phase 1
- A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy MenCompletedNCT05857878Phase 1
- Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk FactorsCompletedNCT05855109
- A Study to Evaluate ATP150/ATP152/ATP162, VSV-GP154 and Ezabenlimab in Patients With Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT05846516Phase 1
- Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This MedicineActive, not recruitingNCT05846230Phase 2
- A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906CompletedNCT05751226Phase 1
- A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the BloodCompletedNCT05738291Phase 1
- A Study to Test How BI 690517 is Taken up in the Body of People With and Without Liver ProblemsCompletedNCT05731908Phase 1
- A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque PsoriasisCompletedNCT05728489Phase 1
- A Study to Compare Tissue and Liquid Biopsies in People With Different Types of CancerActive, not recruitingNCT05708599Not applicable
- Safety of Nintedanib in Real World in ChinaWithdrawnNCT05676112
- PMS of Spesolimab I.V. in GPP Patients With Acute SymptomsCompletedNCT05670821
- A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy MenCompletedNCT05658107Phase 1
- A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD)No longer availableNCT05624281
- A Study in People With Advanced Cancer to Test How BI 907828 is Processed in the BodyCompletedNCT05613036Phase 1
- A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis SymptomsCompletedNCT05559580Phase 2
- A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood ClotWithdrawnNCT05536791